New York, NY -- (SBWIRE) -- 12/18/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Solta Medical Inc (NASDAQ:SLTM), ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), Synovus Financial Corp (NYSE:SNV), DCT Industrial Trust Inc (NYSE:DCT)
Solta Medical Inc (NASDAQ:SLTM) the stock opened the session at $2.92 but then moved to $2.94. At that price, the stock showed a positive performance of 0.68%. Solta Medical, Inc. designs, develops, manufactures and markets professional and consumer energy-based medical device systems for aesthetic applications. The Company's systems are cleared by the United States Food and Drug Administration (FDA) for dermatological procedures performed in the physician led, professional assist, and personal care markets. The Company’s portfolio of products includes six brands that are primarily designed for aesthetic applications:
Will SLTM Continue To Move Higher? Find Out Here
ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) opened the session at $0.86 and closed the session at $0.841. The stock showed a negative performance of -6.80% in previous trading session. ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient’s own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies.
Has IMUC Found The Bottom And Ready To Gain Momentum? Find Out Here
Synovus Financial Corp (NYSE:SNV) opened the session at $3.44 and closed the session at $3.43. The beta of the stock remained 1.99. Synovus Financial Corp. ( Synovus) is a financial services and a bank holding company. The Company provides integrated financial services, including commercial and retail banking, financial management, insurance and mortgage services to its customers through 29 locally-branded banking divisions of its wholly-owned subsidiary bank, Synovus Bank, and other offices in Georgia, Alabama, South Carolina, Florida and Tennessee. Its retail banking services include accepting customary types of demand and savings deposits; mortgage, installment and other retail loans;
Is SNV a Solid Investment at These Levels? Read This Report For Details
DCT Industrial Trust Inc (NYSE:DCT) the stock advanced 0.71% and finished the session at $7.11. The beta of the stock remained 1.55. DCT Industrial Trust Inc. (DCT) is an industrial real estate company that owns, operates and develops bulk distribution and light industrial properties in distribution markets in the United States and Mexico. The Company is structured as an umbrella partnership real estate investment trust (REIT), under which substantially all of its business is, and will be, conducted through a majority-owned and controlled subsidiary, DCT Industrial Operating Partnership LP (the operating partnership), a Delaware limited partnership, for which DCT Industrial Trust Inc.
Will DCT Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)